Skip to content

Clinical trials

Completed Alzheimer Disease trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Completed Country / region: Italy Clear all

84 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20041
20063
20071
20083
20096
20104
20114
20125
20135
20144
20156
20167
20177
20184
20194
20201
20218
20225
20231
20243

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed84

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
H. Lundbeck A/S4
Hoffmann-La Roche4
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia3
Boehringer Ingelheim3
GlaxoSmithKline3
I.R.C.C.S. Fondazione Santa Lucia3
IRCCS Centro San Giovanni di Dio Fatebenefratelli3
Novartis Pharmaceuticals3
Pfizer3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease84
Dementia11
Cognitive Dysfunction9
Neurodegenerative Diseases7
Amyloid Neuropathies, Familial4
Amyloidosis4
Brain Diseases3
Corticobasal Degeneration3
Lewy Body Disease3
Cardiomyopathies2

Trials

Showing 1 to 25 of 84. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.